Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glucuronides | 21 | 2012 | 44 | 5.330 |
Why?
|
Flavonoids | 22 | 2012 | 195 | 5.300 |
Why?
|
Glucuronosyltransferase | 17 | 2012 | 108 | 5.100 |
Why?
|
Genistein | 17 | 2012 | 73 | 3.770 |
Why?
|
Intestinal Absorption | 21 | 2012 | 215 | 3.040 |
Why?
|
Intestinal Mucosa | 22 | 2012 | 1083 | 2.960 |
Why?
|
Isoflavones | 13 | 2009 | 73 | 2.660 |
Why?
|
Caco-2 Cells | 28 | 2012 | 161 | 2.530 |
Why?
|
Phenols | 7 | 2012 | 107 | 2.420 |
Why?
|
Microsomes | 10 | 2010 | 66 | 1.940 |
Why?
|
Microsomes, Liver | 12 | 2012 | 116 | 1.870 |
Why?
|
Tandem Mass Spectrometry | 14 | 2012 | 375 | 1.740 |
Why?
|
Biological Availability | 22 | 2012 | 225 | 1.670 |
Why?
|
ATP-Binding Cassette Transporters | 7 | 2012 | 301 | 1.640 |
Why?
|
Chromatography, High Pressure Liquid | 15 | 2011 | 558 | 1.300 |
Why?
|
Sulfotransferases | 4 | 2012 | 36 | 1.300 |
Why?
|
Flavones | 5 | 2012 | 15 | 1.290 |
Why?
|
Flavonols | 4 | 2011 | 7 | 1.270 |
Why?
|
Biological Transport | 25 | 2012 | 598 | 1.250 |
Why?
|
Intestines | 12 | 2012 | 688 | 1.180 |
Why?
|
Chromatography, Liquid | 10 | 2012 | 350 | 1.130 |
Why?
|
Flavanones | 4 | 2012 | 11 | 0.950 |
Why?
|
Plant Extracts | 4 | 2012 | 223 | 0.940 |
Why?
|
Rats | 32 | 2012 | 6107 | 0.940 |
Why?
|
Apigenin | 8 | 2012 | 12 | 0.930 |
Why?
|
Models, Molecular | 4 | 2012 | 1740 | 0.920 |
Why?
|
Liver | 9 | 2012 | 2902 | 0.900 |
Why?
|
Raloxifene Hydrochloride | 3 | 2010 | 49 | 0.860 |
Why?
|
Ginsenosides | 2 | 2012 | 27 | 0.820 |
Why?
|
Isoenzymes | 4 | 2011 | 608 | 0.800 |
Why?
|
Kinetics | 16 | 2012 | 2041 | 0.800 |
Why?
|
Molecular Structure | 9 | 2012 | 524 | 0.750 |
Why?
|
Spectrophotometry, Ultraviolet | 2 | 2010 | 71 | 0.710 |
Why?
|
Rats, Sprague-Dawley | 18 | 2012 | 2073 | 0.710 |
Why?
|
Cytochrome P-450 Enzyme System | 4 | 2012 | 201 | 0.710 |
Why?
|
Protein Isoforms | 7 | 2011 | 836 | 0.700 |
Why?
|
Administration, Oral | 10 | 2012 | 1555 | 0.630 |
Why?
|
Intestine, Small | 3 | 2008 | 498 | 0.630 |
Why?
|
Anticarcinogenic Agents | 3 | 2012 | 362 | 0.620 |
Why?
|
Recombinant Proteins | 8 | 2012 | 2916 | 0.590 |
Why?
|
Mixed Function Oxygenases | 4 | 2003 | 64 | 0.590 |
Why?
|
Polymyxin B | 3 | 2012 | 53 | 0.590 |
Why?
|
Neoplasm Proteins | 4 | 2012 | 3233 | 0.580 |
Why?
|
Pharmaceutical Preparations | 3 | 2012 | 151 | 0.570 |
Why?
|
Dipeptidases | 5 | 2003 | 16 | 0.570 |
Why?
|
Animals | 51 | 2012 | 59487 | 0.540 |
Why?
|
Substrate Specificity | 7 | 2012 | 552 | 0.500 |
Why?
|
Perfusion | 9 | 2012 | 294 | 0.490 |
Why?
|
Estrone | 2 | 2004 | 32 | 0.490 |
Why?
|
Models, Biological | 9 | 2012 | 3242 | 0.470 |
Why?
|
Drugs, Chinese Herbal | 2 | 2011 | 58 | 0.470 |
Why?
|
Dietary Supplements | 2 | 2010 | 560 | 0.450 |
Why?
|
Estrous Cycle | 1 | 2012 | 37 | 0.430 |
Why?
|
Panax | 1 | 2012 | 33 | 0.420 |
Why?
|
Lactase-Phlorizin Hydrolase | 2 | 2012 | 17 | 0.420 |
Why?
|
Pterocarpans | 2 | 2011 | 6 | 0.420 |
Why?
|
Sulfur Compounds | 1 | 2011 | 4 | 0.420 |
Why?
|
Cephalosporins | 4 | 1996 | 148 | 0.400 |
Why?
|
Alkaloids | 3 | 2011 | 79 | 0.400 |
Why?
|
Quinolizines | 2 | 2011 | 12 | 0.390 |
Why?
|
Trifolium | 2 | 2008 | 5 | 0.390 |
Why?
|
Multidrug Resistance-Associated Proteins | 5 | 2011 | 86 | 0.380 |
Why?
|
Hypericum | 1 | 2010 | 2 | 0.380 |
Why?
|
Hot Temperature | 2 | 2008 | 281 | 0.370 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2010 | 48 | 0.360 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2011 | 507 | 0.360 |
Why?
|
Phytoestrogens | 2 | 2007 | 26 | 0.340 |
Why?
|
Biotransformation | 5 | 2012 | 94 | 0.340 |
Why?
|
Hydrolysis | 6 | 2012 | 229 | 0.340 |
Why?
|
Coumarins | 1 | 2008 | 34 | 0.340 |
Why?
|
Drug Interactions | 6 | 2010 | 556 | 0.330 |
Why?
|
Tissue Distribution | 6 | 2012 | 878 | 0.330 |
Why?
|
Epimedium | 1 | 2008 | 1 | 0.330 |
Why?
|
Humans | 64 | 2012 | 262294 | 0.330 |
Why?
|
Estrogens | 1 | 2012 | 749 | 0.320 |
Why?
|
Injections, Intravenous | 5 | 2012 | 576 | 0.320 |
Why?
|
Quantitative Structure-Activity Relationship | 3 | 2012 | 30 | 0.310 |
Why?
|
Nucleosides | 3 | 2004 | 60 | 0.310 |
Why?
|
Anti-Bacterial Agents | 6 | 2012 | 2996 | 0.310 |
Why?
|
Morphinans | 1 | 2006 | 1 | 0.290 |
Why?
|
Rats, Wistar | 5 | 2011 | 568 | 0.280 |
Why?
|
Quinazolines | 2 | 2004 | 924 | 0.280 |
Why?
|
Cephalexin | 2 | 1996 | 7 | 0.280 |
Why?
|
Glucosides | 1 | 2006 | 66 | 0.280 |
Why?
|
Bile | 3 | 2012 | 82 | 0.280 |
Why?
|
Bridged-Ring Compounds | 1 | 2006 | 183 | 0.270 |
Why?
|
Hydrogen-Ion Concentration | 8 | 2004 | 586 | 0.270 |
Why?
|
gamma-Glutamyl Hydrolase | 1 | 2005 | 12 | 0.270 |
Why?
|
Permeability | 3 | 2012 | 167 | 0.270 |
Why?
|
Benzoates | 1 | 2006 | 134 | 0.260 |
Why?
|
RNA, Small Interfering | 2 | 2011 | 2215 | 0.260 |
Why?
|
Food Labeling | 1 | 2004 | 12 | 0.260 |
Why?
|
Dipeptides | 4 | 1995 | 92 | 0.250 |
Why?
|
Soybean Proteins | 1 | 2004 | 20 | 0.250 |
Why?
|
Polyphenols | 3 | 2010 | 29 | 0.250 |
Why?
|
Methionine | 2 | 1994 | 159 | 0.240 |
Why?
|
Absorption | 3 | 2012 | 81 | 0.240 |
Why?
|
Ginkgo biloba | 1 | 2003 | 16 | 0.230 |
Why?
|
Species Specificity | 4 | 2011 | 774 | 0.230 |
Why?
|
Biological Products | 1 | 2007 | 298 | 0.230 |
Why?
|
Area Under Curve | 4 | 2012 | 701 | 0.230 |
Why?
|
Binding Sites | 3 | 2012 | 2170 | 0.220 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2003 | 62 | 0.220 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 528 | 0.220 |
Why?
|
Male | 31 | 2012 | 123362 | 0.220 |
Why?
|
Up-Regulation | 1 | 2009 | 2450 | 0.210 |
Why?
|
Injections, Intraperitoneal | 2 | 2012 | 196 | 0.210 |
Why?
|
Sulfates | 2 | 2012 | 47 | 0.210 |
Why?
|
Metabolic Detoxication, Phase II | 2 | 2012 | 17 | 0.210 |
Why?
|
Colon | 2 | 2005 | 673 | 0.210 |
Why?
|
Mice | 14 | 2012 | 34391 | 0.210 |
Why?
|
Propionates | 3 | 2009 | 72 | 0.210 |
Why?
|
Metabolic Clearance Rate | 3 | 2012 | 232 | 0.200 |
Why?
|
Metabolic Networks and Pathways | 3 | 2007 | 337 | 0.200 |
Why?
|
Antineoplastic Agents | 5 | 2011 | 14301 | 0.190 |
Why?
|
Cytochrome P-450 CYP3A | 4 | 2012 | 81 | 0.190 |
Why?
|
Biomarkers | 2 | 2011 | 5057 | 0.190 |
Why?
|
Emodin | 2 | 2010 | 15 | 0.190 |
Why?
|
DNA, Complementary | 3 | 2003 | 870 | 0.190 |
Why?
|
Cell Membrane Permeability | 4 | 2004 | 122 | 0.190 |
Why?
|
Mice, Knockout | 5 | 2012 | 5672 | 0.190 |
Why?
|
Catalytic Domain | 2 | 2012 | 305 | 0.190 |
Why?
|
Carrier Proteins | 3 | 2005 | 2023 | 0.180 |
Why?
|
Enzyme Inhibitors | 3 | 2009 | 1879 | 0.180 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 1999 | 122 | 0.170 |
Why?
|
Leukotriene C4 | 2 | 2011 | 8 | 0.170 |
Why?
|
Temperature | 5 | 2004 | 508 | 0.170 |
Why?
|
Gastrointestinal Tract | 2 | 2012 | 328 | 0.160 |
Why?
|
Oxidoreductases | 1 | 1999 | 171 | 0.160 |
Why?
|
Quinolines | 3 | 2009 | 383 | 0.160 |
Why?
|
Thymidylate Synthase | 1 | 1998 | 53 | 0.160 |
Why?
|
Reference Standards | 2 | 2010 | 339 | 0.160 |
Why?
|
Protein Conformation | 2 | 2012 | 1258 | 0.160 |
Why?
|
HeLa Cells | 2 | 2012 | 1642 | 0.160 |
Why?
|
Amino Acid Sequence | 5 | 2012 | 4231 | 0.160 |
Why?
|
Dogs | 4 | 2012 | 1157 | 0.150 |
Why?
|
In Vitro Techniques | 4 | 2009 | 1615 | 0.150 |
Why?
|
Midazolam | 2 | 2012 | 75 | 0.150 |
Why?
|
Lipase | 1 | 1997 | 113 | 0.150 |
Why?
|
Prodrugs | 3 | 2003 | 218 | 0.150 |
Why?
|
Cyclosporine | 2 | 2011 | 282 | 0.150 |
Why?
|
Genetic Vectors | 2 | 1999 | 1681 | 0.140 |
Why?
|
Peptides | 4 | 1996 | 1476 | 0.140 |
Why?
|
Gene Silencing | 2 | 2011 | 835 | 0.140 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 1996 | 77 | 0.140 |
Why?
|
Reproducibility of Results | 4 | 2011 | 6045 | 0.140 |
Why?
|
Phenylalanine | 3 | 2000 | 142 | 0.140 |
Why?
|
Tetrahydroisoquinolines | 1 | 1995 | 24 | 0.130 |
Why?
|
Stereoisomerism | 2 | 2011 | 166 | 0.130 |
Why?
|
Isomerism | 2 | 2011 | 63 | 0.130 |
Why?
|
Isoquinolines | 1 | 1995 | 116 | 0.130 |
Why?
|
Biocatalysis | 2 | 2012 | 65 | 0.130 |
Why?
|
Osmolar Concentration | 2 | 2011 | 203 | 0.130 |
Why?
|
Polymorphism, Genetic | 1 | 2000 | 1448 | 0.130 |
Why?
|
Carcinogens | 3 | 2011 | 382 | 0.120 |
Why?
|
Organic Anion Transporters | 2 | 2004 | 22 | 0.120 |
Why?
|
Epithelium | 5 | 1994 | 718 | 0.120 |
Why?
|
Jejunum | 3 | 2012 | 216 | 0.120 |
Why?
|
Zidovudine | 1 | 1993 | 40 | 0.120 |
Why?
|
Enzyme Stability | 2 | 2007 | 105 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 257 | 0.110 |
Why?
|
Thymidine | 1 | 1993 | 151 | 0.110 |
Why?
|
Verapamil | 2 | 2011 | 79 | 0.110 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 4975 | 0.110 |
Why?
|
Teichoic Acids | 1 | 2012 | 13 | 0.110 |
Why?
|
Diketopiperazines | 1 | 2012 | 5 | 0.110 |
Why?
|
Amino Acids | 3 | 1994 | 727 | 0.110 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2012 | 15 | 0.110 |
Why?
|
Phloretin | 1 | 2012 | 5 | 0.110 |
Why?
|
Kaempferols | 1 | 2012 | 9 | 0.110 |
Why?
|
Arylsulfotransferase | 1 | 2012 | 18 | 0.110 |
Why?
|
Structural Homology, Protein | 1 | 2012 | 43 | 0.110 |
Why?
|
Aconitine | 1 | 2011 | 10 | 0.100 |
Why?
|
Uridine Diphosphate Glucuronic Acid | 1 | 2011 | 8 | 0.100 |
Why?
|
Membrane Transport Modulators | 1 | 2011 | 9 | 0.100 |
Why?
|
Anesthetics, Intravenous | 1 | 2012 | 73 | 0.100 |
Why?
|
Hydrogen Bonding | 1 | 2012 | 128 | 0.100 |
Why?
|
Cells, Cultured | 5 | 2011 | 5598 | 0.100 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 87 | 0.100 |
Why?
|
Tumor Cells, Cultured | 4 | 2011 | 5378 | 0.100 |
Why?
|
Heterocyclic Compounds, 4 or More Rings | 1 | 2012 | 121 | 0.100 |
Why?
|
Testosterone | 3 | 2009 | 620 | 0.100 |
Why?
|
Kidney Tubules, Proximal | 1 | 2012 | 141 | 0.100 |
Why?
|
Microbial Sensitivity Tests | 2 | 2012 | 996 | 0.100 |
Why?
|
Sex Characteristics | 2 | 2011 | 417 | 0.100 |
Why?
|
Glycosides | 1 | 2011 | 23 | 0.100 |
Why?
|
Protein Structure, Secondary | 1 | 2012 | 337 | 0.100 |
Why?
|
Solubility | 1 | 2011 | 246 | 0.100 |
Why?
|
Ovariectomy | 1 | 2012 | 330 | 0.100 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 201 | 0.100 |
Why?
|
Acinetobacter baumannii | 1 | 2011 | 52 | 0.100 |
Why?
|
Cytosol | 1 | 2011 | 237 | 0.100 |
Why?
|
Diterpenes | 1 | 2011 | 112 | 0.090 |
Why?
|
Catalysis | 1 | 2011 | 249 | 0.090 |
Why?
|
Klebsiella pneumoniae | 1 | 2011 | 98 | 0.090 |
Why?
|
Levodopa | 1 | 1990 | 92 | 0.090 |
Why?
|
Drug Stability | 4 | 1999 | 106 | 0.090 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2010 | 94 | 0.090 |
Why?
|
Cathartics | 1 | 2010 | 42 | 0.090 |
Why?
|
Adenosine | 1 | 2012 | 291 | 0.090 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 634 | 0.090 |
Why?
|
Leukotriene Antagonists | 1 | 2009 | 16 | 0.090 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 559 | 0.090 |
Why?
|
Dipyridamole | 1 | 2009 | 33 | 0.090 |
Why?
|
Calibration | 1 | 2011 | 337 | 0.090 |
Why?
|
Sequence Alignment | 1 | 2012 | 843 | 0.090 |
Why?
|
Sodium | 3 | 1998 | 353 | 0.090 |
Why?
|
Butanols | 1 | 2009 | 3 | 0.090 |
Why?
|
Mannitol | 3 | 2000 | 54 | 0.090 |
Why?
|
Molecular Sequence Data | 4 | 2012 | 6062 | 0.090 |
Why?
|
Rats, Gunn | 1 | 2009 | 5 | 0.090 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2009 | 66 | 0.090 |
Why?
|
Glucuronic Acid | 1 | 2009 | 15 | 0.090 |
Why?
|
Berberine | 1 | 2009 | 13 | 0.090 |
Why?
|
Pseudomonas aeruginosa | 1 | 2011 | 231 | 0.090 |
Why?
|
Methyldopa | 1 | 1989 | 5 | 0.090 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 518 | 0.090 |
Why?
|
Captopril | 1 | 1988 | 34 | 0.080 |
Why?
|
Random Allocation | 1 | 2010 | 703 | 0.080 |
Why?
|
Indomethacin | 1 | 2009 | 91 | 0.080 |
Why?
|
Hydroxylation | 2 | 2011 | 62 | 0.080 |
Why?
|
Drug Resistance, Bacterial | 1 | 2012 | 419 | 0.080 |
Why?
|
Glucosidases | 1 | 2008 | 3 | 0.080 |
Why?
|
Hesperidin | 1 | 2008 | 3 | 0.080 |
Why?
|
Quality Control | 1 | 2010 | 459 | 0.080 |
Why?
|
Methotrexate | 1 | 2012 | 1013 | 0.080 |
Why?
|
Azetidines | 1 | 2009 | 88 | 0.080 |
Why?
|
Prenylation | 1 | 2008 | 5 | 0.080 |
Why?
|
Ezetimibe | 1 | 2009 | 101 | 0.080 |
Why?
|
Cell Line | 5 | 2012 | 5071 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 1487 | 0.080 |
Why?
|
Time Factors | 5 | 2012 | 12985 | 0.080 |
Why?
|
Cell Division | 3 | 1999 | 2468 | 0.080 |
Why?
|
Antihypertensive Agents | 1 | 1990 | 395 | 0.080 |
Why?
|
Fungal Proteins | 1 | 2008 | 254 | 0.070 |
Why?
|
Monoterpenes | 1 | 2006 | 10 | 0.070 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2011 | 856 | 0.070 |
Why?
|
Digoxin | 1 | 2006 | 64 | 0.070 |
Why?
|
Rats, Inbred Strains | 1 | 2006 | 410 | 0.070 |
Why?
|
Mouth Neoplasms | 1 | 2011 | 714 | 0.070 |
Why?
|
Camptothecin | 1 | 2009 | 515 | 0.070 |
Why?
|
Anticholesteremic Agents | 1 | 2009 | 256 | 0.070 |
Why?
|
Epithelial Cells | 3 | 2004 | 1818 | 0.070 |
Why?
|
Organ Specificity | 1 | 2007 | 694 | 0.070 |
Why?
|
Membrane Transport Proteins | 2 | 2004 | 246 | 0.070 |
Why?
|
Cell Line, Tumor | 3 | 2012 | 14558 | 0.070 |
Why?
|
Half-Life | 1 | 2005 | 258 | 0.070 |
Why?
|
Plants | 1 | 2005 | 63 | 0.070 |
Why?
|
Escherichia coli | 1 | 2012 | 1214 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2009 | 787 | 0.060 |
Why?
|
Washington | 1 | 2004 | 70 | 0.060 |
Why?
|
Sex Factors | 1 | 2010 | 2156 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2012 | 745 | 0.060 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 935 | 0.060 |
Why?
|
Biliary Tract | 1 | 2004 | 38 | 0.060 |
Why?
|
Female | 10 | 2012 | 142317 | 0.060 |
Why?
|
Serum | 1 | 2004 | 69 | 0.060 |
Why?
|
Oxidoreductases, O-Demethylating | 1 | 2003 | 1 | 0.060 |
Why?
|
Phenacetin | 1 | 2003 | 4 | 0.060 |
Why?
|
Acetophenones | 1 | 2003 | 19 | 0.060 |
Why?
|
Kidney | 1 | 2012 | 2144 | 0.060 |
Why?
|
Binding, Competitive | 2 | 1994 | 300 | 0.060 |
Why?
|
Chromatography, Ion Exchange | 1 | 2003 | 81 | 0.060 |
Why?
|
Chromatography, Gel | 1 | 2003 | 156 | 0.060 |
Why?
|
Estrogen Antagonists | 1 | 2004 | 183 | 0.060 |
Why?
|
Transfection | 2 | 1999 | 2935 | 0.050 |
Why?
|
Phytotherapy | 1 | 2003 | 114 | 0.050 |
Why?
|
Protons | 2 | 1996 | 473 | 0.050 |
Why?
|
Models, Animal | 1 | 2005 | 664 | 0.050 |
Why?
|
beta-Glucosidase | 1 | 2002 | 5 | 0.050 |
Why?
|
Culture Media | 2 | 2012 | 320 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2005 | 4948 | 0.050 |
Why?
|
Propranolol | 2 | 2000 | 155 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2002 | 90 | 0.050 |
Why?
|
Blotting, Northern | 1 | 2003 | 672 | 0.050 |
Why?
|
2,4-Dinitrophenol | 2 | 1992 | 4 | 0.050 |
Why?
|
Dinitrophenols | 2 | 1992 | 5 | 0.050 |
Why?
|
NF-kappa B | 1 | 2009 | 1551 | 0.050 |
Why?
|
Methylation | 1 | 2003 | 591 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2012 | 2812 | 0.050 |
Why?
|
Drug Resistance | 1 | 2003 | 588 | 0.050 |
Why?
|
Cloning, Molecular | 1 | 2003 | 1208 | 0.050 |
Why?
|
Glucuronidase | 2 | 2012 | 50 | 0.050 |
Why?
|
Biological Transport, Active | 2 | 2002 | 131 | 0.050 |
Why?
|
Biomedical Research | 1 | 2007 | 807 | 0.050 |
Why?
|
Sympatholytics | 1 | 1999 | 5 | 0.040 |
Why?
|
Diuretics, Osmotic | 1 | 1999 | 5 | 0.040 |
Why?
|
GABA Modulators | 1 | 1999 | 15 | 0.040 |
Why?
|
Nifedipine | 1 | 1999 | 25 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2000 | 205 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 3758 | 0.040 |
Why?
|
Tritium | 1 | 1999 | 197 | 0.040 |
Why?
|
Catheterization | 1 | 2002 | 410 | 0.040 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1999 | 227 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 1999 | 135 | 0.040 |
Why?
|
Drug Carriers | 2 | 1992 | 327 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 1999 | 591 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2002 | 447 | 0.040 |
Why?
|
Warfarin | 1 | 1999 | 152 | 0.040 |
Why?
|
Ileum | 1 | 1998 | 166 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2006 | 4903 | 0.040 |
Why?
|
Duodenum | 1 | 1998 | 149 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2005 | 1389 | 0.040 |
Why?
|
Cytochrome P-450 CYP2A6 | 1 | 1996 | 18 | 0.040 |
Why?
|
Xenobiotics | 1 | 1996 | 42 | 0.040 |
Why?
|
Purines | 1 | 1998 | 273 | 0.040 |
Why?
|
Base Sequence | 1 | 2003 | 4887 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1999 | 696 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 1999 | 1382 | 0.030 |
Why?
|
Diffusion | 1 | 1995 | 89 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2011 | 5435 | 0.030 |
Why?
|
Liposomes | 1 | 1997 | 682 | 0.030 |
Why?
|
Ouabain | 1 | 1994 | 40 | 0.030 |
Why?
|
Amiloride | 1 | 1994 | 47 | 0.030 |
Why?
|
Gene Expression | 1 | 2003 | 3563 | 0.030 |
Why?
|
Apoptosis | 1 | 2009 | 7603 | 0.030 |
Why?
|
Aging | 1 | 2003 | 1533 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 1999 | 586 | 0.030 |
Why?
|
Basement Membrane | 1 | 1995 | 138 | 0.030 |
Why?
|
Diffusion Chambers, Culture | 1 | 1994 | 9 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 1999 | 839 | 0.030 |
Why?
|
Indoles | 1 | 1999 | 1011 | 0.030 |
Why?
|
Subcellular Fractions | 1 | 1994 | 199 | 0.030 |
Why?
|
Anticoagulants | 1 | 1999 | 791 | 0.030 |
Why?
|
Gluconates | 1 | 2012 | 7 | 0.030 |
Why?
|
Recycling | 1 | 2012 | 6 | 0.030 |
Why?
|
Uranyl Nitrate | 1 | 2012 | 3 | 0.030 |
Why?
|
Glucaric Acid | 1 | 2012 | 12 | 0.030 |
Why?
|
Insulin | 1 | 1999 | 1446 | 0.030 |
Why?
|
Sodium Azide | 1 | 1992 | 8 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 1994 | 189 | 0.030 |
Why?
|
Azides | 1 | 1992 | 32 | 0.030 |
Why?
|
Ions | 1 | 1992 | 54 | 0.030 |
Why?
|
Receptors, Interleukin-1 | 1 | 2012 | 94 | 0.030 |
Why?
|
Pyridines | 1 | 1999 | 1244 | 0.030 |
Why?
|
DNA Topoisomerase IV | 1 | 2012 | 10 | 0.030 |
Why?
|
Lactones | 1 | 2012 | 94 | 0.030 |
Why?
|
Drug Dosage Calculations | 1 | 2012 | 50 | 0.030 |
Why?
|
Benzoxepins | 1 | 2011 | 3 | 0.030 |
Why?
|
Limonins | 1 | 2011 | 3 | 0.030 |
Why?
|
DNA Gyrase | 1 | 2012 | 25 | 0.030 |
Why?
|
Deoxyglucose | 1 | 1992 | 114 | 0.030 |
Why?
|
Ofloxacin | 1 | 2012 | 41 | 0.030 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2011 | 42 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2009 | 5777 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 334 | 0.030 |
Why?
|
Mutation | 1 | 2012 | 15176 | 0.030 |
Why?
|
Levofloxacin | 1 | 2012 | 57 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2012 | 290 | 0.030 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 83 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 2011 | 226 | 0.020 |
Why?
|
Limit of Detection | 1 | 2010 | 82 | 0.020 |
Why?
|
Quinolones | 1 | 2012 | 159 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2003 | 4386 | 0.020 |
Why?
|
Glucose | 2 | 2000 | 1246 | 0.020 |
Why?
|
Chemoprevention | 1 | 2011 | 244 | 0.020 |
Why?
|
Tyrosine | 1 | 2011 | 500 | 0.020 |
Why?
|
Creatinine | 1 | 2012 | 539 | 0.020 |
Why?
|
Escherichia coli Infections | 1 | 2012 | 250 | 0.020 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2009 | 136 | 0.020 |
Why?
|
Excipients | 1 | 1988 | 20 | 0.020 |
Why?
|
Basidiomycota | 1 | 2008 | 9 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2009 | 170 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2009 | 184 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2011 | 465 | 0.020 |
Why?
|
Mathematics | 1 | 1988 | 135 | 0.020 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2012 | 1221 | 0.020 |
Why?
|
beta-Lactams | 1 | 1988 | 52 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 15708 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2011 | 7241 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2012 | 1071 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 625 | 0.020 |
Why?
|
Gene Deletion | 1 | 2012 | 1440 | 0.020 |
Why?
|
Cell Survival | 1 | 2012 | 3042 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 3190 | 0.020 |
Why?
|
Neoplasms | 1 | 2010 | 15198 | 0.010 |
Why?
|
Protein Binding | 1 | 1990 | 3438 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 4808 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 2009 | 7793 | 0.010 |
Why?
|
ErbB Receptors | 1 | 2011 | 2297 | 0.010 |
Why?
|
Pharmacokinetics | 1 | 2002 | 42 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2362 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 2514 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2009 | 1122 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6223 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2062 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 6927 | 0.010 |
Why?
|
Cimetidine | 1 | 2000 | 28 | 0.010 |
Why?
|
Erythromycin | 1 | 2000 | 22 | 0.010 |
Why?
|
Atenolol | 1 | 2000 | 42 | 0.010 |
Why?
|
Insulin Lispro | 1 | 1999 | 2 | 0.010 |
Why?
|
Cresols | 1 | 1999 | 6 | 0.010 |
Why?
|
Adsorption | 1 | 1999 | 46 | 0.010 |
Why?
|
Mammals | 1 | 2000 | 369 | 0.010 |
Why?
|
Signal Transduction | 1 | 2009 | 11971 | 0.010 |
Why?
|